EdgarLookup

VYNE Therapeutics Inc.

VYNE NASDAQ CIK: 0001566044 Pharmaceutical Preparations Inc. in DE
View on SEC.gov →
Overview All Filings Annual Quarterly Insiders

Recent Filings

All 608 filings →
Form Description Date
8-K FORM 8-K Mar 11, 2026
10-K 10-K Feb 27, 2026
425 425 Jan 30, 2026
8-K FORM 8-K Jan 30, 2026
4 Jan 5, 2026
4 Jan 5, 2026
4 Jan 5, 2026
4 Jan 5, 2026
425 425 Dec 17, 2025
8-K FORM 8-K Dec 17, 2025

Insider Transactions

View all →
Insider Title Type Shares Owns After Date
Harsch Mutya CHIEF LEGAL OFFICER AND GC Award / Grant 1,145 @ $0.81 136,646 Jun 2, 2025
Domzalski David PRESIDENT AND CEO Award / Grant 8,681 @ $0.81 454,244 Jun 2, 2025
LEPORE PATRICK G Purchase 15,000 @ $2.92 51,472 Jan 15, 2025
Domzalski David PRESIDENT AND CEO Award / Grant 3,901 @ $2.10 500,597 Nov 30, 2024
Domzalski David PRESIDENT AND CEO Award / Grant 4,429 @ $2.16 498,589 May 31, 2024
Zeronda Tyler Chief Financial Officer Award / Grant 62,500 131,930 Jan 2, 2024
Stuart Iain Chief Scientific Officer Award / Grant 62,500 134,055 Jan 2, 2024
Domzalski David President and CEO Award / Grant 225,000 496,168 Jan 2, 2024
Zeronda Tyler Chief Financial Officer Award / Grant 62,500 69,430 Dec 13, 2023
Stuart Iain Chief Scientific Officer Award / Grant 62,500 71,555 Dec 13, 2023